ArticleOncotarget2017

Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in

Anne-Kathrin Garz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.